Where can I find news about AXGN?

The latest headlines, third-party analysis, and SEC filings for AxoGen, Inc. (AXGN) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are AXGN's SEC filings?

AxoGen, Inc. (AXGN)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are AXGN's earnings call transcripts?

Full earnings call transcripts for AxoGen, Inc. (AXGN), with prepared remarks plus speaker-by-speaker analyst Q&A, live on the Earnings tab alongside the Earnings Reports section that links each quarter's press release and SEC report.

AXGN

AxoGen, Inc.

NASDAQ·Medical, Devices · Healthcare

$38.06$1.38+3.76%

Market cap$2.23B·Market closed·Oct 23 4:00 PM EDT

News & Analysis

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.comOct 21, 2026 · 11:06 AM
GMED or AXGN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or AxoGen (AXGN). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.comOct 16, 2026 · 12:40 PM
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
ALACHUA, Fla. and TAMPA, Fla.
globenewswire.comOct 14, 2026 · 7:00 AM
Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)
The heavy selling pressure might have exhausted for AxoGen (AXGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
zacks.comOct 5, 2026 · 10:35 AM
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
/PRNewswire/ -- Stock Preachers News Commentary - Big technology names pulled the Nasdaq Composite to a weekly gain while the Dow Jones Industrial Average and
prnewswire.comOct 3, 2026 · 7:00 AM
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
ALACHUA, Fla. and TAMPA, Fla.
globenewswire.comOct 1, 2026 · 5:19 PM
Axogen Inc (AXGN) Shares Fall 3.0% -- GF Value Says Still Overvalued
On September 22, 2026, Axogen Inc (AXGN) shares fell by 3.0%, closing at $44.54. The stock is currently trading within a 52-week range of $15.27 to $52.91.
gurufocus.comSep 22, 2026 · 8:09 PM
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Axogen Inc. (NASDAQ:AXGN) on Thursday agreed to acquire a privately held medical device manufacturer, BioCircuit Technologies Inc., for $200 million in cash.
benzinga.comSep 10, 2026 · 12:31 PM

SEC Filings

SC 13G
Oct 2, 2026View on SEC
8-K
Oct 1, 2026View on SEC
424B5
Sep 10, 2026View on SEC
8-K/A
Sep 10, 2026View on SEC
8-K
Sep 10, 2026View on SEC
SC 13G/A
Aug 14, 2026View on SEC

Frequently Asked Questions About AXGN

Where can I find news about AXGN?: The latest headlines, third-party analysis, and SEC filings for AxoGen, Inc. (AXGN) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are AXGN's SEC filings?: AxoGen, Inc. (AXGN)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are AXGN's earnings call transcripts?: Full earnings call transcripts for AxoGen, Inc. (AXGN), with prepared remarks plus speaker-by-speaker analyst Q&A, live on the Earnings tab alongside the Earnings Reports section that links each quarter's press release and SEC report.

AxoGen, Inc.

Frequently Asked Questions About AXGN

AxoGen, Inc.

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

GMED or AXGN: Which Is the Better Value Stock Right Now?

Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026

Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)

Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

Axogen Inc (AXGN) Shares Fall 3.0% -- GF Value Says Still Overvalued

Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair

Frequently Asked Questions About AXGN

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

GMED or AXGN: Which Is the Better Value Stock Right Now?

Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026

Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)

Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

Axogen Inc (AXGN) Shares Fall 3.0% -- GF Value Says Still Overvalued

Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair